Regulation of genetic tests by the Food and Drug Administration (FDA) continues to move forward. Earlier this month, an FDA advisory panel conducted hearings on this subject. The Molecular and Clinical Genetics Panel of FDA’s Medical Devices Advisory Committee discussed several aspects of direct-to-consumer (DTC) genetic testing. Experts on the panel advocated that consumers should […]
To access this post, you must purchase The Dark Report.